PharVision Advisers’s PROS Holdings PRO Stock Holding History

PharVision Advisers’s Portfolio PRO Stock Details PRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-24,573	Closed	-$540K	–	471
2024 Q4	$540K	Buy	+24,573	New	+$528K	0.46%	31

Other funds holding PRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

PharVision Advisers's PRO Position: Q1 2025 in Review

PharVision Advisers sold out of PROS Holdings (PRO) in Q1 2025, closing a stake of 24,573 shares — an estimated $540K sold.

PharVision Advisers first reported a position in PRO in Q4 2024 and held it in 1 quarter. The position peaked at $540K in Q4 2024. 183 funds tracked by Wall St. Rank hold PRO as of Q1 2025.

PharVision Advisers reported no remaining PROS Holdings position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 24,573 PROS Holdings shares in Q1 2025, an estimated $540K.
PharVision Advisers first reported a position in PROS Holdings in Q4 2024 and held it in 1 quarter.
PharVision Advisers's PROS Holdings position peaked at $540K in Q4 2024.
183 funds tracked by Wall St. Rank held PROS Holdings as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.